ALMR
Alamar Biosciences, Inc.
27.80$
-13.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -99.8% | -73.5% | -78.2% | -38.5% | |
| 6.8% | 5.7% | 4.5% | 3.9% | |
| 4.7% | 4.2% | 5.6% | 16.1% | |
| -53.9% | -40.5% | -43.7% | -16.2% | |
| 7.5% | 6.9% | 2.3% | 12.4% | |
| – | – | -3.0% | -410.5% | |
| 0.0% | 0.0% | 217.0% | 0.0% | |
| 1.9% | 1.0% | 214.2% | 685.9% | |
| 33.0% | 40.6% | 248.1% | 232.4% | |
| -107.3% | -80.4% | -80.5% | -50.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.